This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BZAM Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for BZAM.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi54.4%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Cool On BZAM Ltd.'s (CSE:BZAM) Revenues Pushing Shares 36% Lower

Apr 16
Market Cool On BZAM Ltd.'s (CSE:BZAM) Revenues Pushing Shares 36% Lower

Not Many Are Piling Into BZAM Ltd. (CSE:BZAM) Just Yet

Feb 10
Not Many Are Piling Into BZAM Ltd. (CSE:BZAM) Just Yet

BZAM Ltd. (CSE:BZAM) Might Not Be As Mispriced As It Looks After Plunging 26%

Oct 24
BZAM Ltd. (CSE:BZAM) Might Not Be As Mispriced As It Looks After Plunging 26%

Is Green Organic Dutchman Holdings (TSE:TGOD) Using Too Much Debt?

Aug 17
Is Green Organic Dutchman Holdings (TSE:TGOD) Using Too Much Debt?

Auditors Are Concerned About Green Organic Dutchman Holdings (TSE:TGOD)

Mar 13
Auditors Are Concerned About Green Organic Dutchman Holdings (TSE:TGOD)

Things Look Grim For The Green Organic Dutchman Holdings Ltd. (TSE:TGOD) After Today's Downgrade

Mar 12
Things Look Grim For The Green Organic Dutchman Holdings Ltd. (TSE:TGOD) After Today's Downgrade

Green Organic Dutchman Holdings' (TSE:TGOD) Stock Price Has Reduced 65% In The Past Year

Dec 16
Green Organic Dutchman Holdings' (TSE:TGOD) Stock Price Has Reduced 65% In The Past Year

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak BZAM yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

CNSX:BZAM - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
9/30/202382-106-9-8N/A
6/30/202371-97-11-10N/A
3/31/202363-40-14-13N/A
12/31/202249-35-10-9N/A
9/30/202242-33-16-13N/A
6/30/202239-40-19-15N/A
3/31/202235-66-21-16N/A
12/31/202130-39-27-18N/A
9/30/202128-48-36-25N/A
6/30/202123-109-46-26N/A
3/31/202115-85-58-28N/A
12/31/202013-171-87-36N/A
9/30/20209-301-141-49N/A
6/30/20209-246-186-32N/A
3/31/202011-254-269-47N/A
12/31/201911-195-279-57N/A
9/30/201910-69-272-65N/A
6/30/20197-60-258-88N/A
3/31/20194-52-185-81N/A
1/1/20192-45-144-62N/A
9/30/2018N/A-33-87-35N/A
6/30/2018N/A-24-42-22N/A
3/31/2018N/A-18-21-13N/A
12/31/2017N/A-13-10-4N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if BZAM's forecast earnings growth is above the savings rate (2.2%).

Kazançlar ve Piyasa: Insufficient data to determine if BZAM's earnings are forecast to grow faster than the Canadian market

Yüksek Büyüme Kazançları: Insufficient data to determine if BZAM's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if BZAM's revenue is forecast to grow faster than the Canadian market.

Yüksek Büyüme Geliri: Insufficient data to determine if BZAM's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if BZAM's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin